- Report
- October 2024
Global
From €3181EUR$3,500USD£2,701GBP
The Sirolimus Test is an in vitro diagnostic test used to measure the amount of sirolimus in a patient's blood. It is used to monitor the effectiveness of sirolimus-based immunosuppressive therapy in organ transplant patients. The test is also used to diagnose and monitor the progression of certain types of cancer, such as lymphoma and Kaposi's sarcoma. The test is performed in a laboratory setting and requires a sample of the patient's blood.
The Sirolimus Test market is a niche segment of the larger in vitro diagnostics market. It is primarily driven by the increasing prevalence of organ transplantation and the need for effective immunosuppressive therapy. The market is also driven by the increasing prevalence of certain types of cancer, such as lymphoma and Kaposi's sarcoma.
Some of the major companies in the Sirolimus Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Ortho Clinical Diagnostics, and Beckman Coulter. Show Less Read more